General

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

National Cancer Institute
Funder
National Cancer Institute
Funding amount
Varies
Deadline
Jan 8, 2028
Location
N/A

Grant Overview

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) is sponsored by National Cancer Institute. Supports research on molecular imaging of inflammation in cancer, relevant to microenvironment, pathology, and prognostication in lymphoma.

Grant Eligibility

Nonprofit organizations, including 501(c)(3) institutions such as cancer institutes and research centers; universities; and other eligible entities under NIH guidelines.

Grant Contact Information